NCT05833867 2026-03-13
Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer
Case Comprehensive Cancer Center
Phase 1 Recruiting
Clinical Trials
1 trialsLocalized Muscle Invasive Bladder Urothelial Carcinoma × sacituzumab govitecan × 90 days × Clear all